Four prognosis‐associated and glucose metabolism‐related genes (SERP1, CTSC, RAP2B, and SSR4) were ascertained, with the ROC curve results indicating that it may present promising efficacy in predicting the development and outcome of ESCC in both internal and external cohorts. Here, SERP1 is linked to esophageal squamous cell carcinoma.